Patient and Disease–Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics
2019 · Pharmacological Reviews · 200 citations
https://doi.org/10.1124/pr.116.013003
M
Mark Chandy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
1.8K
Citations
18
h-index
23
i10-index
Mark Chandy is an academic researcher from Western University. The author has contributed to research in topics: Genomics and Chromatin Dynamics & Extracellular vesicles in disease & Cardiovascular Function and Risk Factors. The author has an h-index of 18, co-authored 46 publications.
ORCID: 0000-0002-6741-2822Papers by this author
worksAtlas of Exosomal microRNAs Secreted From Human iPSC-Derived Cardiac Cell Types
2020 · Circulation · 31 citations
https://doi.org/10.1161/circulationaha.120.048364
Skin-derived precursors from human subjects with Type 2 diabetes yield dysfunctional vascular smooth muscle cells
2017 · Clinical Science · 3 citations
https://doi.org/10.1042/cs20170239
Recent advances in the cardiotoxicity of anti-cancer drugs: Navigating the landscape of anthracycline-induced cardiotoxicity
2023 · Toxicology and Applied Pharmacology · 3 citations
https://doi.org/10.1016/j.taap.2023.116791
Additional file 2 of MiR-30 promotes fatty acid beta-oxidation and endothelial cell dysfunction and is a circulating biomarker of coronary microvascular dysfunction in pre-clinical models of diabetes
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19234222
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat